OBJECTIVES: To understand community-based treatment in hypertension patients status, care-seeking behavior, medical care, cost burden, and analyze impact factors of their behavior and self-prevention and control effect, China Health Insurance Research Association developed a research on evaluation on drugs and medical cost of hypertension patients in China, and reduce the cost burden of those patients. METHODS: This study collected 1788 valid samples as well as structured questionnaire survey in 3 cities from retrospective study. A more comprehensive medical management and settlement model has provided through an integrated qualitative and quantitative data analysis. The data was analyzed by Spss12.0, discriminant analysis; Chi-square test, one-way MANOVA, and multivariate linear regression analysis. RESULTS: 1)80% outpatients’ cumulative frequency of patients with hypertension concentrates upon about 110 medicines and the spending in these 110 drugs cumulated 75% of all Western medicine fees. The average cost of outpatients in western medicine was RMB 69.4 Yuan; Insurers spent about 97.2% of their premium revenues on patient medicine cost. 2)80% inpatients’ cumulative frequency of patients with hypertension concentrates upon about 100 medicines and the spending in these 100 drugs cumulated 50% of all Western medicine fees. The average cost of inpatients in western medicine was RMB 35.1 Yuan; Insurers spent about 91.3% of their premium on inpatient medicine cost.3) Statistic analysis outcomes show that course of the disease(x1), the type of high blood pressure(x2), the numbers of complications(x3) and the types of Standard management(x4) have significant influence on the total hypertension treatment fees. By multivariate linear regression analysis, a safe regression mode was reached as follows: y=3936.51+1294.309*X3-1239.323*X4. CONCLUSIONS: The categories of drugs administrated by hypertension patients concentrate in large cities, the spending in drugs was lower and the proportion of claims was high. The standard based on community health centers can lower the cost of hypertension treatment.